“Uncovering the Truth: How Regeneron Pharmaceuticals Inc. Investors Can Take Action Against Securities Fraud”
The Impact of the Class Action Lawsuit Against Regeneron Pharmaceuticals, Inc. New York, Jan. 27, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024,…